ReviewCancers2023

Efficacy and Safety of PD-1/PD-L1 Inhibitor as Single-Agent Immunotherapy in Endometrial Cancer: A Systematic Review and Meta-Analysis.

Mohd Nazzary Mamat Yusof et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.